GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Certara Inc (HAM:700) » Definitions » Loans Receivable

Certara (HAM:700) Loans Receivable : €0.0 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Certara Loans Receivable?

Certara's Loans Receivable for the quarter that ended in Mar. 2024 was €0.0 Mil.


Certara Loans Receivable Historical Data

The historical data trend for Certara's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Certara Loans Receivable Chart

Certara Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial - - - - -

Certara Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Certara Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Certara Loans Receivable Related Terms

Thank you for viewing the detailed overview of Certara's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Certara (HAM:700) Business Description

Traded in Other Exchanges
Address
100 Overlook Center, Suite 101, Princeton, NJ, USA, 08540
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA, and other regions, of which a majority of revenue is derived from the United States.

Certara (HAM:700) Headlines

No Headlines